1. Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial. (October 2022) Authors: Peters, N.; Morley, H.; Khalique, S.; Scalzo, S.; Patel, R.; Gunaydin, U.; Funingana, G.; Evans, J.; Papadatos-Pastos, D.; Banjeri, U.; Basu, B.; Niewiarowski, A.; Symeonides, S.; Kelly, F.; Sawretse, L.; Bacon, C.; Robinson, M.; Gelb, T.; Blakemore, S.; Cook, N. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗